Heska Schedules Third Quarter 2016 Earnings Release and Conference Call for November 1, 2016

04:06 EDT 19 Oct 2016 | PR Newswire

LOVELAND, Colo., Oct. 19, 2016 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostics and products, plans to announce its third quarter 2016 financial results in a press release to be issued on Tuesday, November 1, 2016 before the market opens. The Company plans to host a conference call to discuss the results at 9 a.m. MT / 11 a.m. ET on the same day, Tuesday, November 1, 2016.

To access the conference call:

  • From within the United States, please dial 1-888-599-8667
  • From outside of the United States, please dial 1-913-312-1502
  • Reference Conference ID: 9382912

The conference call will be webcast live from the Company's website on

A telephonic replay of the conference call will be available beginning two hours after the end of the call and continue through 11:59 p.m. ET on Tuesday, November 8, 2016.

To access the replay:

  • From within the United States, please dial 1-844-512-2921
  • From outside the United States, please dial 1-412-317-6671
  • Reference Replay Pin Number: 9382912

The webcast will also be archived on until December 31, 2016.

About Heska

Heska Corporation (NASDAQ: HSKA - News) sells advanced veterinary diagnostics and specialty products. Heska's state-of-the-art offerings include blood testing instruments and supplies, digital imaging products, software, and single use offerings such as in-clinic heartworm diagnostic tests, heartworm preventives, allergy immunotherapy and allergy testing. The Company's core focus is on supporting veterinarians in the canine and feline healthcare space.  For further information on Heska and its products, visit the company's website at

At Heska Corporation:

At Hayden IR:

John McMahon, Chief Financial Officer          

Brett Maas, Managing Partner



To view the original version on PR Newswire, visit:

SOURCE Heska Corporation


More From BioPortfolio on "Heska Schedules Third Quarter 2016 Earnings Release and Conference Call for November 1, 2016"

Quick Search

Relevant Topics

Antiretroviral therapy
Standard antiretroviral therapy (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. Huge reductions have been seen in rates of death and suffering whe...

The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...